Abstract
TSG101 was discovered in a screen for tumor susceptibility genes and has since been shown to have a multiplicity of biological effects. However, the basis for TSG101's ability to regulate cell growth has not been elucidated. We report here that the TSG101 protein binds to the cyclin/cyclin-dependent kinase (CDK) inhibitor (CKI) p21 Cip1/WAF1 and increases stability of the p21 protein in HEK293F cells and differentiating primary keratinocytes, suppressing differentiation in a p21-dependent manner. In proliferating keratinocytes where the p21 protein is relatively stable, TSG101 does not affect the stability or expression of p21 but shows p21-dependent recruitment to cyclin/CDK complexes, inhibits cyclin/CDK activity, and causes strong growth suppression to a much greater extent in p21+/+ than in p21−/− cells. Conversely, suppression of endogenous TSG101 expression by an antisense TSG101 cDNA causes doubling of the fraction of keratinocytes in the S phase of the cell cycle as occurs during p21 deficiency. Our results indicate that TSG101 has a direct role in the control of growth and differentiation in primary epithelial cells, and that p21 is an important mediator of these TSG101 functions.
References
35
Referenced
45
10.1101/gad.13.12.1501
- G P Dotto Biochim Biophys Acta 1471, M43–M56 (2000). / Biochim Biophys Acta by Dotto G P (2000)
10.1073/pnas.92.12.5451
10.1101/gad.10.23.3065
10.1073/pnas.96.16.9089
10.1126/science.280.5366.1069
10.1016/S0092-8674(00)81111-3
- M P Lee, A P Feinberg Cancer Res 57, 3131–3134 (1997). / Cancer Res by Lee M P (1997)
10.1038/sj.onc.1201591
10.1038/sj.onc.1202029
10.1073/pnas.98.4.1859
- G H Feng, C J Lih, S N Cohen Cancer Res 60, 1736–1741 (2000). / Cancer Res by Feng G H (2000)
10.1073/pnas.95.4.1595
10.1038/ng0897-330
10.1074/jbc.M009863200
10.1016/S0092-8674(01)00434-2
10.1016/S0092-8674(01)00506-2
10.1073/pnas.98.4.1619
10.1073/pnas.93.19.10315
10.1073/pnas.95.5.2509
10.1177/10454411990100040201
10.1128/MCB.17.1.355
10.1016/S1097-2765(00)80435-9
10.1007/978-1-4615-1809-9_2
10.1093/emboj/20.10.2367
10.1126/science.275.5299.523
10.1128/MCB.20.8.2676-2686.2000
10.1006/bbrc.1998.8547
10.1002/(SICI)1097-0142(19990815)86:4<689::AID-CNCR19>3.0.CO;2-P
10.1101/gad.11.7.847
10.1093/emboj/18.6.1571
10.1101/gad.12.24.3882
10.1038/sj.onc.1202840
- W C Weinberg, E Fernandez-Salas, D L Morgan, A Shalizi, E Mirosh, E Stanulis, C Deng, H Hennings, S H Yuspa Cancer Res 59, 2050–2054 (1999). / Cancer Res by Weinberg W C (1999)
10.1038/sj.onc.1203956
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:45 a.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 6:25 p.m.) |
Indexed | 1 month, 3 weeks ago (July 11, 2025, 6:23 a.m.) |
Issued | 23 years, 4 months ago (April 9, 2002) |
Published | 23 years, 4 months ago (April 9, 2002) |
Published Online | 23 years, 4 months ago (April 9, 2002) |
Published Print | 23 years, 4 months ago (April 16, 2002) |
@article{Oh_2002, title={Negative regulation of cell growth and differentiation by TSG101 through association with p21 Cip1/WAF1}, volume={99}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.082123999}, DOI={10.1073/pnas.082123999}, number={8}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Oh, Hyesun and Mammucari, Cristina and Nenci, Arianna and Cabodi, Sara and Cohen, Stanley N. and Dotto, G. Paolo}, year={2002}, month=apr, pages={5430–5435} }